08 Mar Investing in Canada’s Nanomedicine Ecosystem
NanoCanada and the Nanomedicines Innovation Network are pleased to host a workshop that explores new market potential in the nanomedicine ecosystem. Canada is a proven leader in nanomedicine and the current pandemic has shown the need for a quick response to global challenges. Bringing together key stakeholders in this ecosystem is vital for addressing the current barriers to scale-up.
AGENDA
(EDT)
| 13:30-13:35 | INTRODUCTARY REMARKS Marie D’Iorio, President, NanoCanada |
| 13:35- 14:00 | KEYNOTE TALK John Lewis, Founder & CEO, Entos Pharmaceuticals Ushering in a New Era of Genetic Medicines |
| 14:00 – 14:40 | PANEL DISCUSSION Building Canada’s Advanced Manufacturing Capacity in Nanomedicine MODERATOR Nuzhat Tam-Zaman, Co-Founder & VP Consumer Health, SinoVeda a. Lloyd Jeffs, Senior Director of Clinical Manufacturing Solutions, Precision Nanosystems b. Lakshmi Krishnan, Acting VP Life Sciences, NRC c. Trina Racine, Associate Director – Vaccine Development, The Vaccine and Infectious Disease Organization (VIDO) |
| 14:40-15:10 | KEYNOTE TALK Tom Madden, CEO, Acuitas Therapeutics Supporting COVID-19 Vaccines and Perspective on Future Canadian Pandemic Preparedness |
| 15:10- 15:40 | FUNDING ANNOUNCEMENT Canada’s Nanomedicine Cluster a. Marie D’Iorio, President, NanoCanada b. Stéphane Gagné, CEO, Ovensa c. Ronda Gosselin, Industrial Technology Advisor, Atlantic & Nunavut, NRC-IRAP |
| 15:40-16:05 | KEYNOTE TALK Pieter Cullis, Scientific Director & CEO, The NanoMedicines Innovation Network The Importance of the Scientific Entrepreneur in the Translation of Academic Discoveries into the Commercial World |
| 16:05-16:10 | CONCLUDING REMARKS Diana Royce, Executive Director, The NanoMedicines Innovation Network |
NanoCanada was launched officially in March 2015 to address the urgent need to translate a decade of scientific breakthroughs into the Canadian marketplace. NanoCanada has an exceptional national and international reputation and network that it uses to showcase and launch Canadian innovators in advanced materials and nanotechnology. NanoCanada delivers significant economic impact thanks to its strong leadership and experience, identifying gaps in the Canadian innovation ecosystem, and developing programs to support its community.
NMIN is a federal Networks of Centres of Excellence (NCE) that has mobilized a network of experts and organizations from across sectors – academia, healthcare, industry and other not-for-profit enterprises – to strengthen and extend Canada’s position as a global leader in developing the next generation of nanomedicines.
PROUDLY SUPPORTED BY
